Görgün Güllü, Holderried Tobias A W, Zahrieh David, Neuberg Donna, Gribben John G
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
J Clin Invest. 2005 Jul;115(7):1797-805. doi: 10.1172/JCI24176. Epub 2005 Jun 16.
To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity.
为了研究肿瘤对免疫系统的影响,我们比较了未经治疗的B细胞慢性淋巴细胞白血病(CLL)患者外周血T细胞与年龄匹配的健康供体的外周血T细胞的整体基因表达谱。尽管所分析的细胞不是恶性克隆的一部分,但分析发现了差异表达基因,主要涉及CD4细胞中的细胞分化以及CLL患者CD8细胞中细胞骨架形成、囊泡运输和细胞毒性方面的缺陷。在使用CLL细胞和来自健康异体供体的T细胞进行的共培养实验中,CD4和CD8细胞均出现了类似的缺陷。这些变化仅由直接接触诱导,而非细胞因子介导。确定荷癌患者T细胞中受到干扰的特定途径将使我们能够评估修复这些缺陷的步骤,而增强抗肿瘤免疫力可能需要这些步骤。